Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
08/05/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIDDMiddleby Corp
08/05/202406:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CTRNCiti Trends Inc
08/05/202406:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:QHQuhuo Ltd
08/05/202406:01Business WireHedge Fund Firms Plan Strategic Investment and Business Shifts in Response to Geopolitical, Economic Factors
08/05/202406:01PR Newswire (Canada)ATCO Energy Systems announces its largest ever energy infrastructure project: Yellowhead Mainline to drive economic growth in AlbertaTSX:ACO.XATCO Ltd
08/05/202406:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMCRImmunocore Holdings PLC
08/05/202406:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CTRNCiti Trends Inc
08/05/202406:00Alliance NewsAlliance NewsLONDON MARKET MIDDAY: FTSE 100 hits record again ahead of BoE call
08/05/202406:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:OKEONEOK Inc
08/05/202406:00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:MINDPMIND Technology Inc
08/05/202406:00GlobeNewswire Inc.GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024NASDAQ:GDSGDS Holdings Ltd
08/05/202406:00GlobeNewswire Inc.Kojamo plc Interim Report 1 January–31 March 2024
08/05/202406:00GlobeNewswire Inc.Immunocore reports first quarter financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
08/05/202406:00Business WireAldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye DiseaseNASDAQ:ALDXAldeyra Therapeutics Inc
08/05/202406:00GlobeNewswire Inc.Brunswick Exploration Drills 93.45 Meters at 1.55% Li2O at MR-6TSXV:BRWBrunswick Exploration Inc
08/05/202406:00Business WireEnveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using CannabinoidsNASDAQ:ENVBEnveric Biosciences Inc
08/05/202406:00Business WireQurate Retail, Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:QRTEBQurate Retail Inc
08/05/202406:00Business WireThe Middleby Corporation Reports First Quarter ResultsNASDAQ:MIDDMiddleby Corp
08/05/202406:00Business WireSoftchoice Announces First Quarter 2024 ResultsTSX:SFTCSoftchoice Corporation
08/05/202406:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202406:00GlobeNewswire Inc.C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CCCCC4 Therapeutics Inc
08/05/202406:00GlobeNewswire Inc.Krystal Biotech to Present at BofA Securities 2024 Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
08/05/202406:00GlobeNewswire Inc.REE Automotive Continues to Expand Full by-Wire EV Offering at ACT Expo 2024NASDAQ:REEREE Automotive Ltd
08/05/202406:00GlobeNewswire Inc.EcoSafi announces the first issuance of carbon credits in Africa under high-integrity Gold Standard MECD methodology
08/05/202406:00Business WireCaesarstone Reports First Quarter 2024 Financial ResultsNASDAQ:CSTECaesarstone Ltd
08/05/202406:00GlobeNewswire Inc.Aura Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:AURAAura Biosciences Inc
08/05/202406:00GlobeNewswire Inc.Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersNASDAQ:OMGAOmega Therapeutics Inc
08/05/202406:00GlobeNewswire Inc.Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGWCingulate Inc
08/05/202406:00GlobeNewswire Inc.Hain Celestial Reports Fiscal Third Quarter 2024 Financial ResultsNASDAQ:HAINHain Celestial Group Inc
08/05/202406:00Business WireTEGNA and Indiana Fever Expand Broadcast Distribution of the Fever’s Exciting Upcoming Season in 11 Additional MarketsNYSE:TGNATEGNA Inc